These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14741161)

  • 1. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis.
    Frick KD; Colchero MA; Dean D
    Vaccine; 2004 Jan; 22(5-6):689-96. PubMed ID: 14741161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of trachoma and economics of the disease.
    Frick KD; Hanson CL; Jacobson GA
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):1-10. PubMed ID: 14692674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness.
    Eko FO; Talin BA; Lubitz W
    Hum Vaccin; 2008; 4(3):176-83. PubMed ID: 18382139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global burden of trachoma: a review.
    Burton MJ; Mabey DC
    PLoS Negl Trop Dis; 2009 Oct; 3(10):e460. PubMed ID: 19859534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trachoma: transmission, infection, and control.
    Gambhir M; Basáñez MG; Turner F; Kumaresan J; Grassly NC
    Lancet Infect Dis; 2007 Jun; 7(6):420-7. PubMed ID: 17521595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trachoma and antibiotic use: the 'A' in SAFE.
    West S
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):75-83. PubMed ID: 22149616
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chavda VP; Pandya A; Kypreos E; Patravale V; Apostolopoulos V
    Expert Rev Vaccines; 2022 Jun; 21(6):771-781. PubMed ID: 35470769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enlightenment of blinding trachoma elimination in China.
    Hu A; Wang N
    Sci China Life Sci; 2017 Dec; 60(12):1453-1456. PubMed ID: 29285712
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of molecular tools in the control of blinding trachoma.
    Mabey D; Solomon AW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):11-7. PubMed ID: 14692675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis.
    Solomon AW; Mabey DC
    Vaccine; 2005 Nov; 23(46-47):5281-2. PubMed ID: 16122846
    [No Abstract]   [Full Text] [Related]  

  • 13. CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.
    Olivares-Zavaleta N; Whitmire WM; Kari L; Sturdevant GL; Caldwell HD
    J Immunol; 2014 May; 192(10):4648-54. PubMed ID: 24711617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and control of trachoma: systematic review.
    Hu VH; Harding-Esch EM; Burton MJ; Bailey RL; Kadimpeul J; Mabey DC
    Trop Med Int Health; 2010 Jun; 15(6):673-91. PubMed ID: 20374566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review of the SAFE strategy for the prevention of blinding trachoma.
    Kuper H; Solomon AW; Buchan J; Zondervan M; Foster A; Mabey D
    Lancet Infect Dis; 2003 Jun; 3(6):372-81. PubMed ID: 12781509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a safe and effective chlamydial vaccine: lessons from the eye.
    Mabey DC; Hu V; Bailey RL; Burton MJ; Holland MJ
    Vaccine; 2014 Mar; 32(14):1572-8. PubMed ID: 24606636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trachoma: an overview.
    Burton MJ
    Br Med Bull; 2007; 84():99-116. PubMed ID: 18175788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New fly trap may reduce prevalence of blindness from trachoma.
    Dobson R
    Bull World Health Organ; 2000; 78(10):1282. PubMed ID: 11100624
    [No Abstract]   [Full Text] [Related]  

  • 19. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention.
    Zhang H; Kandel RP; Sharma B; Dean D
    Arch Ophthalmol; 2004 Apr; 122(4):511-6. PubMed ID: 15078668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.